Mukilteo Beacon - Your Hometown News Source

Multiple vaccines are being studied for prevention of COVID-19 and one of them is being considered for emergency use for high-risk populations, by the end of the year.

Pfizer's COVID-19 vaccine is under review by the FDA on Dec. 10. If approved for emergency use, it could be made available to high- risk populations by the end of December. The World Health Organization reports that 15% of COVID-19 infections are "severe infection, requiring oxygen and 5% are critical infections, requiring ventilation."

On Dec. 10, Pfizer intends to present information to the FDA that includes safety data fro...